iShares iBoxx $ Inv Grade Corporate Bond ETF vs Liquidia Corporation Common Stock — how do they compare? iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $103.58 (market cap $29.07B), while Liquidia Corporation Common Stock trades at $34.5 (market cap $2.40B). The key difference: iShares iBoxx $ Inv Grade Corporate Bond ETF is far larger — about 12.1× Liquidia Corporation Common Stock's market cap, and iShares iBoxx $ Inv Grade Corporate Bond ETF is more actively traded (26,122,352 versus 2,857,547). Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ Inv Grade Corporate Bond ETF for 126 Days and Liquidia Corporation Common Stock for 0 Days on average.
| LQD | LQDA | |
|---|---|---|
Market Cap | $29.07B | $2.40B |
Volume | 26,122,352 | 2,857,547 |
Sector | Fixed Income | Health |
52-Week High | $112.91 | $91.03 |
52-Week Low | $101.83 | $22.02 |
Typical Hold Time | 126 Days | 0 Days |
Enterprise Value | — | $2.30B |
Signals from Pluang's Aura AI — not financial advice
LQD trades at $102.55, down slightly by 0.03% on the day, with technical indicators signaling a bearish trend as selling pressure outweighs buying. The ETF faces headwinds from rising bond yields and increased short interest, which grew 53.1% in September. Recent dividends of $0.44-$0.46 provide income support, but the overall market sentiment remains cautious amid a challenging fixed-income environment.
The outlook for LQD is constrained by persistent bond market volatility and higher interest rates, which pressure corporate bond valuations. While the ETF's investment-grade portfolio offers relative safety, further yield increases could limit upside. Key risks include Fed policy uncertainty and economic slowdown concerns, warranting a neutral to cautious stance for equity-focused investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →